Drug Armamentarium for alopecia areata

---

Review Article

Author Details : Sunil Chaudhry*

Volume : 8, Issue : 2, Year : 2020

Article Page : 49-59

https://doi.org/10.18231/j.jpbs.2020.008

Suggest article by email

Get Permission

---

Abstract

Alopecia areata (AA) is a nonscarring, autoimmune hair loss on the scalp, and/or body. The AA occurs in people of all ages and affects 1–2%. Patients with the disease can face significant emotional and psychological stress as a result, there is no cure for the condition. Many therapeutic modalities have been used to treat alopecia areata, with variable efficacy and safety profiles. Unfortunately, none of these agents is curative or preventive. The treatment plan is designed according to the patient’s age and extent of disease. Global Alopecia Treatment Market is valued at USD 2.54 billion in 2018 and expected to reach USD3.98
billion by 2025 with the CAGR of 5.80% over the forecast period.

Keywords: Alopecia areata, Corticosteroids, JAK inhibitors, Minoxidil.

How to cite : Chaudhry S , Drug Armamentarium for alopecia areata. J Pharm Biol Sci 2020;8(2):49-59

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.